S100A8 and coronary artery disorder: Anti-CagA antibodies are suspected to cross-react with self-antigens exposed on the surface and/or present in the cytoplasm of endothelial cells, thereby triggering inflammation and deteriorating vascular lesions underlying coronary heart diseases, cerebral stroke, and preeclampsia44, 45.